These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37061873)

  • 41. Breast cancer risk stratification in women of screening age: Incremental effects of adding mammographic density, polygenic risk, and a gene panel.
    Evans DGR; van Veen EM; Harkness EF; Brentnall AR; Astley SM; Byers H; Woodward ER; Sampson S; Southworth J; Howell SJ; Maxwell AJ; Newman WG; Cuzick J; Howell A
    Genet Med; 2022 Jul; 24(7):1485-1494. PubMed ID: 35426792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multi-ancestry polygenic risk scores for venous thromboembolism.
    Jee YH; Thibord F; Dominguez A; Sept C; Boulier K; Venkateswaran V; Ding Y; Cherlin T; Verma SS; Faro VL; Bartz TM; Boland A; Brody JA; Deleuze JF; Emmerich J; Germain M; Johnson AD; Kooperberg C; Morange PE; Pankratz N; Psaty BM; Reiner AP; Smadja DM; Sitlani CM; Suchon P; Tang W; Trégouët DA; Zöllner S; Pasaniuc B; Damrauer SM; Sanna S; Snieder H; ; Kabrhel C; Smith NL; Kraft P;
    Hum Mol Genet; 2024 Sep; 33(18):1584-1591. PubMed ID: 38879759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age at diagnosis of cancer in 185delAG BRCA1 mutation carriers of diverse ethnicities: tentative evidence for modifier factors.
    Laitman Y; Michaelson-Cohen R; Chen-Shtoyerman R; Goldberg Y; Reish O; Bernstein-Molho R; Levy-Lahad E; Baruch NEB; Kedar I; Evans DG; Haim S; Paluch-Shimon S; Friedman E
    Fam Cancer; 2021 Jul; 20(3):189-194. PubMed ID: 33165727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A streamlined model for use in clinical breast cancer risk assessment maintains predictive power and is further improved with inclusion of a polygenic risk score.
    Allman R; Spaeth E; Lai J; Gross SJ; Hopper JL
    PLoS One; 2021; 16(1):e0245375. PubMed ID: 33481864
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Breast cancer risk prediction using a clinical risk model and polygenic risk score.
    Shieh Y; Hu D; Ma L; Huntsman S; Gard CC; Leung JW; Tice JA; Vachon CM; Cummings SR; Kerlikowske K; Ziv E
    Breast Cancer Res Treat; 2016 Oct; 159(3):513-25. PubMed ID: 27565998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women.
    Shieh Y; Fejerman L; Lott PC; Marker K; Sawyer SD; Hu D; Huntsman S; Torres J; Echeverry M; Bohórquez ME; Martínez-Chéquer JC; Polanco-Echeverry G; Estrada-Flórez AP; ; Haiman CA; John EM; Kushi LH; Torres-Mejía G; Vidaurre T; Weitzel JN; Zambrano SC; Carvajal-Carmona LG; Ziv E; Neuhausen SL
    J Natl Cancer Inst; 2020 Jun; 112(6):590-598. PubMed ID: 31553449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of Breast Cancer Polygenic Risk Scores in 760 Female CHEK2 Germline Mutation Carriers.
    Borde J; Ernst C; Wappenschmidt B; Niederacher D; Weber-Lassalle K; Schmidt G; Hauke J; Quante AS; Weber-Lassalle N; Horváth J; Pohl-Rescigno E; Arnold N; Rump A; Gehrig A; Hentschel J; Faust U; Dutrannoy V; Meindl A; Kuzyakova M; Wang-Gohrke S; Weber BHF; Sutter C; Volk AE; Giannakopoulou O; Lee A; Engel C; Schmidt MK; Antoniou AC; Schmutzler RK; Kuchenbaecker K; Hahnen E
    J Natl Cancer Inst; 2021 Jul; 113(7):893-899. PubMed ID: 33372680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study.
    Yang X; Leslie G; Gentry-Maharaj A; Ryan A; Intermaggio M; Lee A; Kalsi JK; Tyrer J; Gaba F; Manchanda R; Pharoah PDP; Gayther SA; Ramus SJ; Jacobs I; Menon U; Antoniou AC
    J Med Genet; 2018 Aug; 55(8):546-554. PubMed ID: 29730597
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polygenic risk scores for cigarettes smoked per day do not generalize to a Native American population.
    Otto JM; Gizer IR; Bizon C; Wilhelmsen KC; Ehlers CL
    Drug Alcohol Depend; 2016 Oct; 167():95-102. PubMed ID: 27530288
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polygenic prediction of breast cancer: comparison of genetic predictors and implications for risk stratification.
    Läll K; Lepamets M; Palover M; Esko T; Metspalu A; Tõnisson N; Padrik P; Mägi R; Fischer K
    BMC Cancer; 2019 Jun; 19(1):557. PubMed ID: 31182048
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population-specific validation and comparison of the performance of 77- and 313-variant polygenic risk scores for breast cancer risk prediction.
    Hovhannisyan M; Zemankova P; Nehasil P; Matejkova K; Borecka M; Cerna M; Dolezalova T; Dvorakova L; Foretova L; Horackova K; Jelinkova S; Just P; Kalousova M; Kral J; Machackova E; Nemcova B; Safarikova M; Springer D; Stastna B; Tavandzis S; Vocka M; Zima T; Soukupova J; Kleiblova P; Ernst C; Kleibl Z; Janatova M
    Cancer; 2024 Sep; 130(17):2978-2987. PubMed ID: 38718029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical profile of breast cancer in Arab and Jewish women in the Jerusalem area.
    Nissan A; Spira RM; Hamburger T; Badrriyah M; Prus D; Cohen T; Hubert A; Freund HR; Peretz T
    Am J Surg; 2004 Jul; 188(1):62-7. PubMed ID: 15219486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breast Cancer Polygenic Risk Score Validation and Effects of Variable Imputation.
    Beck JJ; Slunecka JL; Johnson BN; Van Asselt AJ; Finnicum CT; Ageton C; Krie A; Nickles H; Cowan K; Maxwell J; Boomsma DI; de Geus E; Ehli EA; Hottenga JJ
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672660
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic variants demonstrating flip-flop phenomenon and breast cancer risk prediction among women of African ancestry.
    Wang S; Qian F; Zheng Y; Ogundiran T; Ojengbede O; Zheng W; Blot W; Nathanson KL; Hennis A; Nemesure B; Ambs S; Olopade OI; Huo D
    Breast Cancer Res Treat; 2018 Apr; 168(3):703-712. PubMed ID: 29302764
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
    Li H; Feng B; Miron A; Chen X; Beesley J; Bimeh E; Barrowdale D; John EM; Daly MB; Andrulis IL; Buys SS; Kraft P; ; Thorne H; Chenevix-Trench G; Southey MC; Antoniou AC; James PA; Terry MB; Phillips KA; Hopper JL; Mitchell G; Goldgar DE
    Genet Med; 2017 Jan; 19(1):30-35. PubMed ID: 27171545
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence of nonfounder BRCA1/2 mutations in Ashkenazi Jewish patients presenting for genetic testing at a hereditary breast and ovarian cancer center.
    Frey MK; Kopparam RV; Ni Zhou Z; Fields JC; Buskwofie A; Carlson AD; Caputo T; Holcomb K; Chapman-Davis E
    Cancer; 2019 Mar; 125(5):690-697. PubMed ID: 30480775
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gene- and pathway-level analyses of iCOGS variants highlight novel signaling pathways underlying familial breast cancer susceptibility.
    Lonjou C; Eon-Marchais S; Truong T; Dondon MG; Karimi M; Jiao Y; Damiola F; Barjhoux L; Le Gal D; Beauvallet J; Mebirouk N; Cavaciuti E; Chiesa J; Floquet A; Audebert-Bellanger S; Giraud S; Frebourg T; Limacher JM; Gladieff L; Mortemousque I; Dreyfus H; Lejeune-Dumoulin S; Lasset C; Venat-Bouvet L; Bignon YJ; Pujol P; Maugard CM; Luporsi E; Bonadona V; Noguès C; Berthet P; Delnatte C; Gesta P; Lortholary A; Faivre L; Buecher B; Caron O; Gauthier-Villars M; Coupier I; Mazoyer S; Monraz LC; Kondratova M; Kuperstein I; Guénel P; Barillot E; Stoppa-Lyonnet D; Andrieu N; Lesueur F
    Int J Cancer; 2021 Apr; 148(8):1895-1909. PubMed ID: 33368296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
    Huntley C; Torr B; Sud A; Rowlands CF; Way R; Snape K; Hanson H; Swanton C; Broggio J; Lucassen A; McCartney M; Houlston RS; Hingorani AD; Jones ME; Turnbull C
    Lancet Oncol; 2023 Jun; 24(6):658-668. PubMed ID: 37178708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The rate of the recurrent MSH6 mutations in Ashkenazi Jewish breast cancer patients.
    Bernstein-Molho R; Laitman Y; Schayek H; Iomdin S; Friedman E
    Cancer Causes Control; 2019 Jan; 30(1):97-101. PubMed ID: 30498870
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in Three Major Racial and Ethnic Groups.
    Dikilitas O; Schaid DJ; Kosel ML; Carroll RJ; Chute CG; Denny JA; Fedotov A; Feng Q; Hakonarson H; Jarvik GP; Lee MTM; Pacheco JA; Rowley R; Sleiman PM; Stein CM; Sturm AC; Wei WQ; Wiesner GL; Williams MS; Zhang Y; Manolio TA; Kullo IJ
    Am J Hum Genet; 2020 May; 106(5):707-716. PubMed ID: 32386537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.